Department of Dermatology, Liverpool Hospital, Liverpool, Sydney, Australia.
Faculty of Medicine, University of New South Wales, Sydney, Australia.
Clin Exp Dermatol. 2019 Jun;44(4):e126-e132. doi: 10.1111/ced.13922. Epub 2019 Feb 7.
BACKGROUND: Hidradenitis suppurativa (HS) is a debilitating and distressing chronic inflammatory skin disease. There is also evolving evidence supporting the association between HS and cardiovascular risk factors, including smoking, obesity, hyperlipidaemia and metabolic syndrome. Notably, these are clinical features and risk factors that are closely associated with type 2 diabetes mellitus (DM). AIMS: We performed a pooled adjusted meta-analysis of comparative studies to investigate the relationship between HS and DM. METHODS: A systematic review and meta-analysis was performed according to recommended Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. OR was used as the summary effect size. RESULTS: From pooled analysis of unadjusted data from 12 studies, we found a significantly higher proportion of DM in HS cases compared with non-HS healthy controls (16.1% vs. 15.7%; OR = 2.17; 95% CI 1.85-2.55; P < 0.001). Adjusted effect sizes from five studies were also pooled. A significantly higher proportion of DM was found for HS compared with healthy controls, although the effect size was attenuated compared with unadjusted analyses (OR 1.69; 95% CI 1.50-1.91; P < 0.001). CONCLUSIONS: To our knowledge, our systematic review and meta-analysis is the first to pool adjusted effect sizes. We found that HS was associated with a 1.69-fold increased odds of diabetes; however, the absolute risk difference was small (16.1% vs. 15.7%) and is probably not clinically relevant. Treating clinicians should be aware of this association, but there may not be an urgent need to perform screening for impaired glucose tolerance or diabetes.
背景:化脓性汗腺炎(HS)是一种使人衰弱和痛苦的慢性炎症性皮肤病。也有越来越多的证据支持 HS 与心血管危险因素之间的关联,包括吸烟、肥胖、高脂血症和代谢综合征。值得注意的是,这些是与 2 型糖尿病(DM)密切相关的临床特征和危险因素。
目的:我们对比较研究进行了汇总调整后的荟萃分析,以研究 HS 与 DM 之间的关系。
方法:根据系统评价和荟萃分析的推荐的 Preferred Reporting Items 进行了系统评价和荟萃分析。OR 被用作汇总效应大小。
结果:从 12 项研究的未调整数据的汇总分析中,我们发现 HS 病例中 DM 的比例明显高于非 HS 健康对照组(16.1%对 15.7%;OR=2.17;95%CI 1.85-2.55;P<0.001)。也对五项研究的调整后效应大小进行了汇总。与健康对照组相比,HS 组 DM 的比例明显更高,尽管与未调整分析相比,效应大小减弱(OR 1.69;95%CI 1.50-1.91;P<0.001)。
结论:据我们所知,我们的系统评价和荟萃分析是首次汇总调整后的效应大小。我们发现 HS 与糖尿病的发病风险增加 1.69 倍有关;然而,绝对风险差异较小(16.1%对 15.7%),可能在临床上并不相关。治疗医生应该意识到这种关联,但可能没有迫切需要进行葡萄糖耐量受损或糖尿病的筛查。
Clin Exp Dermatol. 2019-2-7
Int J Dermatol. 2019-5-31
Actas Dermosifiliogr (Engl Ed). 2019-5
J Am Acad Dermatol. 2018-1-12
JAMA Dermatol. 2014-12
Arch Dermatol Res. 2025-1-8
Curr Issues Mol Biol. 2023-5-17